AB BioTechnologies, a privately-held pharmaceutical contract service provider, is expanding its services to include pre-clinical manufacturing at its Bloomington, IN, facility. New drug candidates must undergo pre-clinical studies to establish a toxicology profile and assess the safety, efficacy and bioactivity prior to filing an investigational new drug (IND) application. AB BioTechnologies has the capabilities and experience to perform the early-stage development work—formulation, process, ...